Skip to main content

Rohypnol

Volume 400: debated on Tuesday 4 March 2003

The text on this page has been created from Hansard archive content, it may contain typographical errors.

To ask the Secretary of State for Northern Ireland if he will make a statement on the availability of Rohypnol in Northern Ireland; and what mechanisms are in place to ensure that Rohypnol is attained by the public solely for its prescribed purpose. [98374]

Rohypnol (Flunitrazepam) is subject to the same legal controls and prescribing restrictions in Northern Ireland as are in force within the rest of the UK. It is a prescription only medicine (POM) which may be only prescribed on private prescription. It is a Schedule 3 drug under the Misuse of Drugs Regulations (Northern Ireland) 2002 and as such prescriptions written for it must comply with both prescription and handwriting requirements under the Regulations.Stocks of the product are subject to safe custody requirements. The Misuse of Drugslnspector (NI) is responsible for inspection and monitoring activities and enforcement action where appropriate. Routine and unannounced inspections are carried out on practitioners, pharmacists, trust and private hospitals, pharmaceutical manufacturers and wholesalers, and research and clinical trial establishments to ensure compliance with legislative controls, agreed standard operating procedures, good practice guidelines and safe custody requirements.